Rocket Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $417.6M | $130.6M |
| Jun 2022 | — | $387.7M | $187.5M |
| Sep 2022 | — | $367.3M | $196.7M |
| Dec 2022 | — | $489.7M | $140.5M |
| Mar 2023 | — | $458.9M | $64.6M |
| Jun 2023 | — | $403.0M | $45.1M |
| Sep 2023 | — | $541.1M | $225.7M |
| Dec 2023 | — | $492.6M | $55.9M |
| Mar 2024 | — | $441.5M | $35.3M |
| Jun 2024 | — | $384.6M | $38.6M |
| Sep 2024 | — | $329.8M | $65.6M |
| Dec 2024 | — | $463.2M | $163.6M |
| Mar 2025 | — | $412.1M | $49.8M |
| Jun 2025 | — | $354.2M | $32.8M |
| Sep 2025 | — | $313.7M | $75.9M |
| Dec 2025 | — | $277.2M | $77.6M |
| Mar 2026 | — | $238.0M | $49.6M |
| Jun 2026 | — | $368.8M | $224.5M |